FDA com­mis­sion­er spells out agen­cy's top pri­or­i­ties, with a fo­cus on dis­pelling mis­in­for­ma­tion

It’s been a lit­tle more than six months since FDA com­mis­sion­er Rob Califf won Sen­ate con­fir­ma­tion, and while he high­light­ed some of his key goals ear­ly on, he of­fered the agency’s lat­est ar­ray of top pri­or­i­ties in a JA­MA view­point yes­ter­day af­ter­noon.

At the top of the list, even as gen­er­al fa­tigue has tak­en hold among the pub­lic’s per­cep­tion to­ward the pan­dem­ic, is Covid-19, and the on­go­ing opi­oid ad­dic­tion cri­sis, which took more than 100,000 lives in 2021.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER